Clinical Trial Update: Pegylated Liposomal Doxorubicin and Docetaxel in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By Surgery [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pegylated liposomal doxorubicin with docetaxel in locally advanced breast cancer that could be removed by surgery; the study was termin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Doxil (liposomal doxorubicin)
• Taxotere (docetaxel)

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Breast Cancer | Phase 2 | Status: TERMINATED | Results posted: 2014-08-22